GUILDFORD, England--(BUSINESS WIRE)--Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery ...
The FDA has granted over-the-counter marketing authorization to MED3000 (Eroxon), the first nonprescription topical gel for treating erectile dysfunction (ED) in men age 22 and older, maker Futura ...
Futura Medical has reported phase 3 data on its topical erectile dysfunction treatment MED3000, teeing it up to file for FDA approval of the therapy as an over-the-counter medicine by the end of the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a confirmatory study, MED3000 was associated with ...
- Company also announced that it raised proceeds of £4,375,000 to fund future commercialization of MED3000 via a warrant exercise by a large institutional shareholder - GUILDFORD, England, June 12, ...
WHEN YOU’RE DEALING with erectile dysfunction, you usually have to make an appointment with your doctor to get treated. But, soon, you’ll be able to pick up medication at your local pharmacy without a ...
While the Pittsburgh region might be a straggler when it comes to the state-of-the-art in medical practice management, it hasn’t hindered MED3000 from becoming a premier player in the field. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results